Benjamin F. Edwards & Company, Inc. Guardant Health, Inc. Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 100 shares of GH stock, worth $4,953. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Previous 200 50.0%

Holding current value

$4,953

Previous $4,000 25.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$16.07 - $31.84 $1,607 - $3,184	-100 Reduced 50.0%	100 $3,000
Q1 2024 Apr 29, 2024	SELL	$17.13 - $26.91 $3,014 - $4,736	-176 Reduced 46.81%	200 $4,000
Q4 2023 Feb 06, 2024	SELL	$21.58 - $29.5 $4,855 - $6,637	-225 Reduced 37.44%	376 $10,000
Q2 2023 Aug 15, 2023	SELL	$20.94 - $38.01 $2,094 - $3,801	-100 Reduced 14.27%	601 $22,000
Q1 2023 Apr 27, 2023	SELL	$22.92 - $33.76 $2,292 - $3,376	-100 Reduced 12.48%	701 $16,000
Q4 2022 Feb 07, 2023	SELL	$25.44 - $59.78 $6,690 - $15,722	-263 Reduced 24.72%	801 $22,000
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $7,262 - $19,492	-252 Reduced 19.15%	1,064 $43,000
Q1 2022 May 04, 2022	SELL	$48.25 - $100.49 $1,013 - $2,110	-21 Reduced 1.57%	1,316 $87,000
Q4 2021 Feb 07, 2022	BUY	$88.71 - $120.43 $11,532 - $15,655	130 Added 10.77%	1,337 $134,000
Q3 2021 Nov 02, 2021	SELL	$98.77 - $132.17 $20,741 - $27,755	-210 Reduced 14.82%	1,207 $151,000
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $508 - $716	-4 Reduced 0.28%	1,417 $216,000
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $4,498 - $6,116	45 Added 3.27%	1,421 $183,000
Q3 2020 Nov 13, 2020	SELL	$80.32 - $111.8 $1,927 - $2,683	-24 Reduced 1.71%	1,376 $154,000
Q2 2020 Aug 14, 2020	SELL	$60.49 - $97.5 $17,965 - $28,957	-297 Reduced 17.5%	1,400 $114,000
Q1 2020 May 07, 2020	BUY	$59.04 - $88.81 $11,630 - $17,495	197 Added 13.13%	1,697 $118,000
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $27,439 - $78,384	800 Added 114.29%	1,500 $115,000
Q4 2018 Jan 31, 2019	BUY	$29.2 - $46.1 $20,440 - $32,270	700 New	700 $26,000

Others Institutions Holding GH

# of Institutions

393

Shares Held

121M

Call Options Held

1.43M

Put Options Held

2.37M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $5.06B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Guardant Health, Inc. Transaction History